Boston Partners’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
Other funds holding ACH
Boston Partners's ACH Position: Q4 2022 in Review
Boston Partners sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 605,659 shares — an estimated $14M sold.
Boston Partners first reported a position in ACH in Q2 2013 and held it in 19 quarters. The position peaked at $24.1M in Q1 2016. 217 funds tracked by Wall St. Rank hold ACH as of Q4 2022.
- Boston Partners reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
- Boston Partners sold 605,659 Accendra Health shares in Q4 2022, an estimated $14M.
- Boston Partners first reported a position in Accendra Health in Q2 2013 and held it in 19 quarters.
- Boston Partners's Accendra Health position peaked at $24.1M in Q1 2016.
- 217 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.
Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.